| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
106,883,000 |
| Market
Cap: |
1.04(M) |
| Last
Volume: |
9,926 |
Avg
Vol: |
77,919 |
| 52
Week Range: |
$0.009725 - $0.047 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tss4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tss4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Defiante Farmaceutica Lda |
10% Owner |
– – • |
2004-01-23 |
4 |
B |
$0.95 |
$999,999 |
I/I |
1,052,631 |
8,492,663 |
1.5 |
- |
|
| Hindin Richard J |
Director |
– • – |
2004-01-23 |
4 |
B |
$0.95 |
$75,000 |
D/D |
78,947 |
1,592,710 |
2.39 |
- |
|
| Mcnay Joseph C |
Director |
– • – |
2004-01-23 |
4 |
B |
$0.95 |
$100,000 |
D/D |
105,263 |
1,142,795 |
2.39 |
- |
|
| Hindin Richard J |
Director |
– • – |
2004-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
157,478 |
1,513,763 |
|
- |
|
| Finkelstein J J |
President and CEO |
• • – |
2004-01-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
22,500 |
|
- |
|
| Finkelstein J J |
President and CEO |
• • – |
2004-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
1,596,138 |
|
- |
|
| Hindin Richard J |
Director |
– • – |
2003-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
238,759 |
1,671,241 |
|
- |
|
| Goldstein Allan L |
Director |
– • – |
2003-07-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
81,103 |
1,989,320 |
|
- |
|
| Goldstein Allan L |
Director |
– • – |
2003-07-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(45,103) |
99,206 |
|
- |
|
| Goldstein Allan L |
Director |
– • – |
2003-07-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
51,103 |
144,309 |
|
- |
|
| Hindin Richard J |
Director |
– • – |
2003-07-03 |
4 |
OE |
$0.10 |
$2,500 |
D/D |
25,000 |
1,910,000 |
|
- |
|
| Cavazza Claudio |
10% Owner |
– – • |
2003-06-11 |
4 |
B |
$0.63 |
$2,000,000 |
I/I |
3,184,713 |
7,440,032 |
1.5 |
- |
|
| Cavazza Paolo |
10% Owner |
– – • |
2003-06-11 |
4 |
B |
$0.63 |
$2,000,000 |
I/I |
3,184,713 |
7,440,032 |
1.5 |
- |
|
| Cavazza Claudio |
10% Owner |
– – • |
2002-03-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,255,319 |
|
- |
|
| Cavazza Paolo |
10% Owner |
– – • |
2002-03-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,255,319 |
|
- |
|
140 Records found
|
|
Page 6 of 6 |
|
|
